Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E2007 for Levodopa-Induced Dyskinesia in Parkinson's Disease
NCT00451633Phase 2Withdrawn
- Sponsor
- Eisai Co., Ltd.
- Start
- Mar 2007
- Modality
- Classical Binding Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of perampanel in levodopa-induced dyskinesia (LID), sponsored by Eisai Co., Ltd.. Planned start Mar 2007; status: withdrawn.
02
Drugs
perampanel
03
Conditions
levodopa-induced dyskinesia (LID)
Beyond the preview
Go deeper on NCT00451633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00451633.